Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Free Cash Flow (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Free Cash Flow for 5 consecutive years, with -$3.8 million as the latest value for Q4 2020.

  • Quarterly Free Cash Flow fell 412.53% to -$3.8 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$18.4 million through Dec 2020, down 528.13% year-over-year, with the annual reading at -$51.0 million for FY2025, 65.73% down from the prior year.
  • Free Cash Flow for Q4 2020 was -$3.8 million at Forte Biosciences, up from -$7.7 million in the prior quarter.
  • The five-year high for Free Cash Flow was $16.2 million in Q2 2019, with the low at -$17.8 million in Q1 2019.
  • Average Free Cash Flow over 5 years is -$5.8 million, with a median of -$7.4 million recorded in 2016.
  • The sharpest move saw Free Cash Flow surged 241.59% in 2019, then tumbled 1213.92% in 2020.
  • Over 5 years, Free Cash Flow stood at -$7.3 million in 2016, then dropped by 23.21% to -$8.9 million in 2017, then decreased by 29.83% to -$11.6 million in 2018, then skyrocketed by 93.61% to -$742000.0 in 2019, then crashed by 412.53% to -$3.8 million in 2020.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$3.8 million, -$7.7 million, and -$4.0 million for Q4 2020, Q3 2020, and Q2 2020 respectively.